185 related articles for article (PubMed ID: 16885916)
1. Management of locally advanced renal cell carcinoma.
Rodriguez A; Sexton WJ
Cancer Control; 2006 Jul; 13(3):199-210. PubMed ID: 16885916
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.
Zisman A; Wieder JA; Pantuck AJ; Chao DH; Dorey F; Said JW; Gitlitz BJ; deKernion JB; Figlin RA; Belldegrun AS
J Urol; 2003 Mar; 169(3):909-16. PubMed ID: 12576811
[TBL] [Abstract][Full Text] [Related]
3. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of venous tumor thrombus in renal cell carcinoma].
García-Fadrique G; Budía-Alba A; Ruiz-Cerdá JL; Morales-Solchaga G; Pontones JL; Jiménez-Cruz JF
Actas Urol Esp; 2012 Jan; 36(1):29-34. PubMed ID: 21802784
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis.
Tsuji Y; Goto A; Hara I; Ataka K; Yamashita C; Okita Y; Kamidono S
J Vasc Surg; 2001 Apr; 33(4):789-96. PubMed ID: 11296333
[TBL] [Abstract][Full Text] [Related]
8. Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance.
Zini L; Destrieux-Garnier L; Leroy X; Villers A; Haulon S; Lemaitre L; Koussa M
J Urol; 2008 Feb; 179(2):450-4; discussion 454. PubMed ID: 18076946
[TBL] [Abstract][Full Text] [Related]
9. [Local recurrence of renal cell carcinoma after nephrectomy].
Pereverzev AS; Shchukin DV; Iliukhin IuA
Urologiia; 2003; (6):14-8. PubMed ID: 14708237
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for high-risk renal cell carcinoma patients.
Kunkle DA; Haas NB; Uzzo RG
Curr Urol Rep; 2007 Jan; 8(1):19-30. PubMed ID: 17239313
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy.
Di Silverio F; Sciarra A; Parente U; Andrea A; Von Heland M; Panebianco V; Passariello R
Urol Int; 2008; 80(4):451-3. PubMed ID: 18587261
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma.
Wood E; Donin N; Shuch B
Urol Clin North Am; 2020 Aug; 47(3):345-358. PubMed ID: 32600536
[TBL] [Abstract][Full Text] [Related]
13. Integration of surgery and systemic therapy for renal cell carcinoma.
Kenney PA; Wood CG
Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
[TBL] [Abstract][Full Text] [Related]
14. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma.
Belldegrun A; Shvarts O; Figlin RA
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S88-92. PubMed ID: 10685666
[TBL] [Abstract][Full Text] [Related]
15. Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma.
Ficarra V; Righetti R; D'Amico A; Rubilotta E; Novella G; Malossini G; Mobilio G
Oncology; 2001; 61(1):10-5. PubMed ID: 11474242
[TBL] [Abstract][Full Text] [Related]
16. Current surgical approaches, nephron-sparing surgery, and the role of surgery in the integrated immunologic approach to renal-cell carcinoma.
Novick AC
Semin Oncol; 1995 Feb; 22(1):29-33. PubMed ID: 7855616
[No Abstract] [Full Text] [Related]
17. May Adjuvant Therapy Play A Role for the Management of Renal Cell Carcinoma? A Review of Literature and Ongoing Trials.
Messina C; Zanardi E; Boccardo F
Anticancer Agents Med Chem; 2017; 17(12):1633-1643. PubMed ID: 28270065
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
[TBL] [Abstract][Full Text] [Related]
19. Therapy of locally recurrent renal cell carcinoma after nephrectomy.
Tanguay S; Pisters LL; Lawrence DD; Dinney CP
J Urol; 1996 Jan; 155(1):26-9. PubMed ID: 7490850
[TBL] [Abstract][Full Text] [Related]
20. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
